CareToLive RSS
Subscribe to the CareToLive RSS feed for up to date news and developments surrounding the legal battle against the FDA and more. (RSS feed reader required)
Subscribe to the CareToLive RSS feed for up to date news and developments surrounding the legal battle against the FDA and more. (RSS feed reader required)
Spread The Word
Please help spread the word about CareToLive. Any of the information found on this website can be distributed and shared freely. We only ask that you provide a link back to this website if you publish our content.
Please help spread the word about CareToLive. Any of the information found on this website can be distributed and shared freely. We only ask that you provide a link back to this website if you publish our content.
Donations
CareToLive is a not for profit corporation; however, donations are NOT tax exempt.
CareToLive is a not for profit corporation; however, donations are NOT tax exempt.
Posts Tagged ‘taxotere’
Provenge is approved!
- Provenge has been approved! Thank you to all who helped achieve this important milestone for cancer patients.
LATEST POSTS
- 02/06/2012 - Great Provenge News Released At ASCO
- 11/27/2011 - Care To Live Board Member Ted Girgus Dies of Prostate Cancer
- 09/06/2011 - Care To Live Update on SEC OIG Investigation into April 28, 2009 Dendreon Bear Raid
- 07/13/2011 - 3 Minute Video Explaining Provenge Treatment
- 06/20/2011 - Abigail Alliance Plans FDA PROTEST June 28
- 06/09/2011 - RIP Charles A. Reinwald — Cancer Cure Coalition Founder
- 04/29/2011 - Care To Live Submits Moment of Silence to CMS
- 04/28/2011 - HHS Desperately Needs Transparency Lessons From CMS
- 04/23/2011 - Please Post for Provenge!
- 04/19/2011 - Another Interim Provenge Prostate Cancer Immunotherapy CMS FOIA Response
MOST POPULAR
- Setting the Record Straight
- Provenge Is Approved But The Lies Continue
- Provenge Works & Costs the Same as Chemo & Comments by Bishop
- The Bloodshed, Bogus Threats, Birth Defects, Bashers Cover Letter
- PROVENGE WILL BE COVERED BY MEDICARE
- CareToLive sends a Freedom of Information Request to the Centers for Medicare & Medicaid Services
- ASCO Tells CMS It Should Cover Provenge
- The Centers for Medicare and Medicaid Services are requesting comments.
- Dr. Snuffy Myers Advocates For Provenge Treatment
- Senators Specter and Kerry - CMS Has Some 'Splaining To Do
WHATS GOING ON
This Is An Emergency!
We rallied outside the FDA building in Rockville, Maryland on September 18th. Now there are buses riding around Rockville and Washington, D.C., further protesting the shenanigans that took place inside the FDA building, as well as outside.
The FDA has gotten caught up with Wall Street. While it is supposed to be busy with evaluating food and drugs, its employees just can't keep their eyes off the money. So that is how decisions are being made these days.
This Is An Emergency!
We rallied outside the FDA building in Rockville, Maryland on September 18th. Now there are buses riding around Rockville and Washington, D.C., further protesting the shenanigans that took place inside the FDA building, as well as outside.
The FDA has gotten caught up with Wall Street. While it is supposed to be busy with evaluating food and drugs, its employees just can't keep their eyes off the money. So that is how decisions are being made these days.
WE'LL BE BACK
These people traveled from all across the country to protest outside the FDA Building in Rockville, Maryland. The FDA has stopped a safe and effective treatment from getting to men who need it now. The treatment is called Provenge and it treats men who have late stage prostate cancer.
The FDA appointed a panel of experts to help it decide on the safety and efficacy of Provenge. That panel voted 17-0 that Provenge was safe. And it voted 13-4 that Provenge showed substantial evidence it worked. And yet the FDA delayed it. Now it could be a year, a year and a half or it could be three years. It could be forever.
These people will keeping coming back to Rockville and they hope others will join them until the courts, the FDA, Congress or somebody does something about this travesty.
These people traveled from all across the country to protest outside the FDA Building in Rockville, Maryland. The FDA has stopped a safe and effective treatment from getting to men who need it now. The treatment is called Provenge and it treats men who have late stage prostate cancer.
The FDA appointed a panel of experts to help it decide on the safety and efficacy of Provenge. That panel voted 17-0 that Provenge was safe. And it voted 13-4 that Provenge showed substantial evidence it worked. And yet the FDA delayed it. Now it could be a year, a year and a half or it could be three years. It could be forever.
These people will keeping coming back to Rockville and they hope others will join them until the courts, the FDA, Congress or somebody does something about this travesty.
CareToLive Files Complaint Against FDA for Violation of Freedom of Information Act
January 2nd, 2008 | Posted by CTLNow comes Plaintiff CareToLive, a not for profit corporation and advocacy group organized and incorporated under the laws of and in Ohio, and hereby asserts the following causes of action against the Defendant, Food and Drug Administration (FDA), commissioner Andrew von Eschenbach.
Complaint Against the FDA for Violation of Freedom of Information Act (click link)
CareToLive is asking the public to help get to the bottom of the Provenge debacle by joining Congressmen Mike Michaud of Maine, Dan Burton of Indiana, and Tim Ryan of Ohio, who are calling for a congressional hearing into what happened. Contact your elected officials to ask for a congressional hearing, visiting the CareToLive website, dig our blogs, and join in the battle.
30,000 American men will die each year (not to mention the rest of the world) without this safe and effective immunotherapy. 1 in 6 men will get prostate cancer int heir lifetime. The FDA’s delay of Provenge was unprecedented in a terminal disease with an overwhelmingly positive panel that showed survival advantages, where no other options exist. Only one treatment for prostate cancer has been approved in 42 years. Send a clear message to Congress, the dysfunctional FDA, Wall Street, and the Chemo Cartel that we want this nontoxic immunotherapy approved NOW! More than 10 years of trials have shown it increases survival. Some men are alive as long as 6 years.
CONGRESSIONAL LETTER ASKING FOR A HEARING PDF (click here) Please fax this letter to your own congressional representatives and ask them to join this action. TIA
An Easy Way To Contact Your Elected Officials - (click here) EVERY VOICE COUNTS!
Continue Reading CareToLive Files Complaint Against FDA for Violation of Freedom of Information Act »
Popularity: 8%
Tags: , Andrew Von Eschenbach, Brachytherapy, Care To Live, CareToLive, Dendreon, FDA, foia, Freedom of Information Act, Kerry Donahue, Prostate Cancer, provenge, sloan kettering, taxotere
Posted in The Cause | 1 Comment »
That Stupid Clown At The Prostate Cancer Rally Is Dead Serious
January 1st, 2008 | Posted by CTLCareToLive Spokesperson Mike Kearney (VIDEO LINK)
Mr. Kearney has a horse in this race. He is genetically predisposed to prostate cancer having one uncle who died from it and another uncle currently undergoing brachytherapy. 1 in 6 men will get prostate cancer in their lifetime.
Click this link to go to blog on Dr. Noah Prostate and Video of DC Rally.
Three Lawmakers Give Terminal Cancer Patients Early Xmas Gift —Evelyn Pringles gives a good summary of the Provenge debacle. (click link)
To the Silly 66 and Company who dugg our blog, thanks for playing. Let’s make 2008 the Year of Provenge Approval. We wish everybody a Happy and Healthy New Year!
CareToLive is asking the public to help get to the bottom of the Provenge debacle by contacting their elected officials to ask for a congressional hearing, visiting the CareToLive website, digging our blogs, and joining in the battle. 30,000 American men will die each year (not to mention the rest of the world) without this safe and effective immunotherapy.
The FDA’s delay of Provenge was unprecedented in a terminal disease with an overwhelmingly positive panel that showed survival advantages, where no other options exist. Only one treatment for prostate cancer has been approved in 42 years.Send a clear message to Congress, the dysfunctional FDA, Wall Street, and the Chemo Cartel that we want this nontoxic immunotherapy approved NOW! More than 10 years of trials have shown it increases survival. Some men are alive as long as 6 years.
Congressmen Mike Michaud of Maine, Dan Burton of Indiana, and Tim Ryan of Ohio are calling for a congressional hearing into what happened. We must continue to be vigilant and to contact our representatives in the Congress to keep the pressure on, and to demand a congressional hearing.
CONGRESSIONAL LETTER ASKING FOR A HEARING PDF (click here) Please fax this letter to your own congressional representatives and ask them to join this action. TIA
This link will take you right to a page to send a form to the committee Continue Reading That Stupid Clown At The Prostate Cancer Rally Is Dead Serious »
Popularity: 7%
Tags: Brachytherapy, Care To Live, CareToLive, Dendreon, FDA, Immunotherapy, Prostate Cancer, provenge, Richard Pazdur, sloan kettering, taxotere
Posted in The Cause | 5 Comments »